Arun Nagarajan (@arunnagarajanmd) 's Twitter Profile
Arun Nagarajan

@arunnagarajanmd

Section Head for GI Oncology, Cleveland Clinic, Florida.

ID: 982755382073245696

calendar_today07-04-2018 23:01:56

80 Tweet

454 Followers

548 Following

Hagop Kantarjian,MD (@drhkantarjian) 's Twitter Profile Photo

Generic imatinib at $47/month directly from manufacturer = more patients with #CML can afford treatment and live normal life doi.org/10.1016/S2352-… via The Lancet Haematology #leusm

Generic imatinib at $47/month directly from manufacturer = more patients with #CML can afford treatment and live normal life
doi.org/10.1016/S2352-… via <a href="/TheLancetHaem/">The Lancet Haematology</a> 
#leusm
Pashtoon Kasi MD, MS (@pashtoonkasi) 's Twitter Profile Photo

Sounds like we were popular JCO Precision Oncology ASCO👇🏾. Hanging out with the cool kids. Sam Klempner Brandon Huffman, MD Daniel Catenacci Joseph Chao Gregory Botta @DayyaniFarshid 🩸#ctDNA is here to stay. OncoAlert #LiquidBiopsies Here’s the link to the full paper: ascopubs.org/doi/full/10.12…

Sounds like we were popular <a href="/JCOPO_ASCO/">JCO Precision Oncology</a> <a href="/ASCO/">ASCO</a>👇🏾.

Hanging out with the cool kids.

<a href="/KlempnerSam/">Sam Klempner</a> <a href="/BHuffmanMD/">Brandon Huffman, MD</a> <a href="/DocCatenacci/">Daniel Catenacci</a> <a href="/JoeChaoMD/">Joseph Chao</a> <a href="/gregorybotta/">Gregory Botta</a> @DayyaniFarshid 

🩸#ctDNA is here to stay.

<a href="/OncoAlert/">OncoAlert</a> #LiquidBiopsies 

Here’s the link to the full paper:
ascopubs.org/doi/full/10.12…
Arun Nagarajan (@arunnagarajanmd) 's Twitter Profile Photo

ASCO GI24: Delighted to represent Cleveland Clinic Florida in this study: ctDNA status after neoadjuvant therapy correlates with clinical and pathological response and survival outcomes.

ASCO GI24:  Delighted to represent Cleveland Clinic Florida in this study: ctDNA status after neoadjuvant therapy correlates with clinical and pathological response and survival outcomes.
Arndt Vogel (@arndtvogel) 's Twitter Profile Photo

Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC Journal of Hepatology doi.org/10.1016/j.jhep… 🔎systematic review, 91 pts 👉26.4% rejections & 9.9% deaths 👉washout length⬆️ > allograft rejection risk⬇️ 🧐Important data to optimize outcome

Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC
<a href="/JHepatology/">Journal of Hepatology</a> 
doi.org/10.1016/j.jhep…
🔎systematic review, 91 pts
👉26.4% rejections &amp; 9.9% deaths
👉washout length⬆️ &gt; allograft rejection risk⬇️
🧐Important data to optimize outcome